newsfilter
← Latest News
ACCESS Newswire·

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza vaccine currently in Phase